Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10618905 Pyrimidine-based compounds for the treatment of cancer

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1061890500
Edits on 10 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 May, 2023
Edits on 22 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Apr, 2023
Infobox
Patent Citations
‌
US Patent 10189851 CDK inhibitors
0
Edits on 5 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 5 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
G1 Therapeutics
G1 Therapeutics
0
Current Assignee
G1 Therapeutics
G1 Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
106189050
Date of Patent
April 14, 2020
0
Patent Application Number
162304120
Date Filed
December 21, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=106189050
Patent Citations
‌
US Patent 10076523 HSPC-sparing treatments for RB-positive abnormal cellular proliferation
0
‌
US Patent 10085992 Transient protection of normal cells during chemotherapy
0
‌
US Patent 10189849 CDK inhibitors
0
‌
US Patent 10189850 CDK inhibitors
0
‌
US Patent 10189851 CDK inhibitors
0
‌
US Patent 10231969 Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors
0
Patent Citations Received
‌
US Patent 11364222 Combination therapy for treatment of cancer
0
Patent Primary Examiner
‌
Alexander R Pagano
0
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations
‌
US Patent 10189850 CDK inhibitors
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
G1 Therapeutics
G1 Therapeutics
0
Current Assignee
G1 Therapeutics
G1 Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
106189050
Date of Patent
April 14, 2020
0
Patent Application Number
162304120
Date Filed
December 21, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=106189050
Patent Citations
‌
US Patent 10076523 HSPC-sparing treatments for RB-positive abnormal cellular proliferation
0
‌
US Patent 10085992 Transient protection of normal cells during chemotherapy
0
‌
US Patent 10189849 CDK inhibitors
0
‌
US Patent 10189850 CDK inhibitors
0
‌
US Patent 10189851 CDK inhibitors
0
‌
US Patent 10231969 Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors
0
Patent Citations Received
‌
US Patent 11364222 Combination therapy for treatment of cancer
0
Patent Primary Examiner
‌
Alexander R Pagano
0
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations
‌
US Patent 10189851 CDK inhibitors
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 22 Jun, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11364222 Combination therapy for treatment of cancer
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10618905
Edits on 2 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 2 Feb, 2022
Edits made to:
Infobox (+15 properties)
‌

 US Patent 10618905 Pyrimidine-based compounds for the treatment of cancer

Infobox
Is a
Patent
Patent
Patent applicant
G1 Therapeutics
G1 Therapeutics
Current assignee
G1 Therapeutics
G1 Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10618905
Date of patent
April 14, 2020
Patent application number
16230412
Date Filed
December 21, 2018
Patent citations
‌
US Patent 10076523 HSPC-sparing treatments for RB-positive abnormal cellular proliferation
‌
US Patent 10085992 Transient protection of normal cells during chemotherapy
‌
US Patent 10189849 CDK inhibitors
‌
US Patent 10189850 CDK inhibitors
‌
US Patent 10189851 CDK inhibitors
‌
US Patent 10231969 Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors
Patent primary examiner
‌
Alexander R Pagano

Find more entities like US Patent 10618905 Pyrimidine-based compounds for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.